标题:Sulfotanshinone Sodium Injection could decrease fibrinogen level and improve clinical outcomes in patients with unstable angina pectoris
作者:Yan, Fang-fang; Liu, Yun-Fang; Liu, Yan; Zhao, Yu-Xia
作者机构:[Yan, FF; Liu, YF; Liu, Y; Zhao, YX]Shandong Univ, Chinese Minist Educ, Sch Med, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250012, Shando 更多
通讯作者:Zhao, YX
通讯作者地址:[Zhao, YX]Shandong Univ, Qilu Hosp, Dept Tradit Chinese Med, 107 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.
来源:INTERNATIONAL JOURNAL OF CARDIOLOGY
出版年:2009
卷:135
期:2
页码:254-255
DOI:10.1016/j.ijcard.2008.03.020
关键词:Unstable angina pectoris; Fibrinogen; D-dimer; Sulfotanshinone Sodium; Injection
摘要:We randomly divided 100 unstable angina pectoris (UAP) patients into two groups: the trial group received Sulfotanshinone Sodium Injection (SSI) 60 mg combined with a loading dose of 300 mg aspirin and a maintenance dose of 100 mg of aspirin plus baseline therapy, and the control group received the same doses of aspirin and baseline therapy. 94 patients completed treatment. After 4 weeks' medication, the severity of angina pectoris improved in both groups, with a significant improvement in total effective rate in the trial group but no difference in the total effective rate of improvement seen on ECG. Compared with baseline level, FIB level after treatment decreased significantly in both groups but to a greater extent in the trial group. Similar changes in DD levels were observed in both groups. With a background of aspirin and baseline therapy, SSI can significantly attenuate angina pectoris attacks in patients with UAP which may be associated with the decreased level of FIB. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
收录类别:SCOPUS;SCIE
WOS核心被引频次:10
Scopus被引频次:9
资源类型:期刊论文
原文链接:https://www.scopus.com/inward/record.uri?eid=2-s2.0-67349103443&doi=10.1016%2fj.ijcard.2008.03.020&partnerID=40&md5=eaed4e78db19860d878cddfb07ba6ab1
TOP